Effect of Vitamin D receptor gene polymorphism on vitamin D therapy for postmenopausal bone loss

Makoto Owada, Kumiko Suzuki, Tsuyoshi Honda, Hidekazu Yamada, Susumu Tsukikawa, Kazuhiko Hoshi, Akira Sato

    Research output: Contribution to journalArticle

    3 Citations (Scopus)

    Abstract

    In order to assess the effect of vitamin D receptor (VDR) gene polymorphisms on vitamin D3 therapy for postmenopausal bone loss. Thirty- four Japanese postmenopausal women, administer ed vitamin D3 (Alfarol® 1.0μg/day) and Ca (2.0g/day) for 18 months, were analyzed by RFLP Bone mineral density (BMI) at the lumber spine (L2-4) and Os-calcis were measured every 6 months by dual energy X-ray absorptiometry (DXA) and single energy X-ray absorptiometry (SXA) VDR gene allelic polymorphisms were assessed by Bsm 1 endonuclease restriction after specific PCR amplification. Genotypic polymorphism was defined as BB, bb and Bb. The genotypes were BB in 1 (3.1%) Bb in 13 (40.6%) and bb in 18 (56.3%). The women in these two major VDR genotype groups (Bb and bb) were similar in their backgrounds (interms of age, menopausal age, body mass index, and BMD in premedication), but the VDR genotype was associated the percent of change in BMD after treatment. In Group-Bb, the mean percent increases in L2-4 BMD were 3.2%, 4.9% and 4.1% at 6, 12 and 18 months. In contrast, in Group-bb they were 0.8%, 1.8% and 4.2% at the same points. Analysis of VDR alleles may prove useful in selecting the vitamin D therapy for osteopenia before treatment.

    Original languageEnglish
    Pages (from-to)799-805
    Number of pages7
    JournalActa Obstetrica et Gynaecologica Japonica
    Volume48
    Issue number9
    Publication statusPublished - 1996 Sep 1

    Keywords

    • Bone mineral density
    • Polymorphism
    • Vitamin D
    • Vitamin D receptor

    ASJC Scopus subject areas

    • Obstetrics and Gynaecology

    Fingerprint Dive into the research topics of 'Effect of Vitamin D receptor gene polymorphism on vitamin D therapy for postmenopausal bone loss'. Together they form a unique fingerprint.

  • Cite this

    Owada, M., Suzuki, K., Honda, T., Yamada, H., Tsukikawa, S., Hoshi, K., & Sato, A. (1996). Effect of Vitamin D receptor gene polymorphism on vitamin D therapy for postmenopausal bone loss. Acta Obstetrica et Gynaecologica Japonica, 48(9), 799-805.